Jemperli Interactions
There are 597 drugs known to interact with Jemperli (dostarlimab), along with 3 disease interactions. Of the total drug interactions, 3 are major, and 594 are moderate.
- View all 597 medications that may interact with Jemperli
- View Jemperli disease interactions (3)
Most frequently checked interactions
View interaction reports for Jemperli (dostarlimab) and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Advair HFA (fluticasone / salmeterol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- alprazolam
- amitriptyline
- amoxicillin
- apixaban
- Arexvy (rsv vaccine pref3, recombinant)
- aspirin
- Ativan (lorazepam)
- atorvastatin
- bempedoic acid
- benzonatate
- Bonine (meclizine)
- Bystolic (nebivolol)
- caffeine
- carboplatin
- cefdinir
- cefpodoxime
- cefuroxime
- Celebrex (celecoxib)
- cephalexin
- cetirizine
- chlorhexidine topical
- chloroquine
- ciprofloxacin
- citalopram
- hydroxychloroquine
- methocarbamol
- prednisone
Jemperli disease interactions
There are 3 disease interactions with Jemperli (dostarlimab) which include:
Report options
QR code containing a link to this page
More about Jemperli (dostarlimab)
- Jemperli consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
